<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T14:27:28Z</responseDate>
  <request identifier="oai:figshare.com:article/34048238" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34048238</identifier>
        <datestamp>2026-10-01T17:31:21Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_8</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_16</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Histopathological examination of splenic tissue stained with hematoxylin and eosin.&lt;/p&gt;</dc:title>
          <dc:creator>Naim Gheymoumi (25157753)</dc:creator>
          <dc:creator>Sevda Shayesteh (25157756)</dc:creator>
          <dc:creator>Fatemeh Sharifi (3496619)</dc:creator>
          <dc:creator>Marziyeh Amiri-Andebili (25157759)</dc:creator>
          <dc:creator>Hediyeh Gheymoumi (25157762)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Microbiology</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>potential immunometabolic modulator</dc:subject>
          <dc:subject>following ova sensitization</dc:subject>
          <dc:subject>endogenous tryptophan metabolite</dc:subject>
          <dc:subject>elevated serum ige</dc:subject>
          <dc:subject>aryl hydrocarbon receptor</dc:subject>
          <dc:subject>serum inflammatory markers</dc:subject>
          <dc:subject>including increased sneezing</dc:subject>
          <dc:subject>mucosal immune regulation</dc:subject>
          <dc:subject>systemic inflammatory mediators</dc:subject>
          <dc:subject>study investigated kyna</dc:subject>
          <dc:subject>findings support kyna</dc:subject>
          <dc:subject>marked inflammatory changes</dc:subject>
          <dc:subject>xlink "&gt; rats</dc:subject>
          <dc:subject>local regulatory cytokines</dc:subject>
          <dc:subject>ar remain unclear</dc:subject>
          <dc:subject>systemic effects comparable</dc:subject>
          <dc:subject>ahr signaling contributes</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>regulatory cytokines</dc:subject>
          <dc:subject>systemic anti</dc:subject>
          <dc:subject>inflammatory infiltration</dc:subject>
          <dc:subject>histopathological changes</dc:subject>
          <dc:subject>inflammatory effects</dc:subject>
          <dc:subject>cytokine regulation</dc:subject>
          <dc:subject>associated regulation</dc:subject>
          <dc:subject>ahr signaling</dc:subject>
          <dc:subject>kyna ),</dc:subject>
          <dc:subject>splenic tissues</dc:subject>
          <dc:subject>splenic histopathology</dc:subject>
          <dc:subject>kynurenic acid</dc:subject>
          <dc:subject>indicating involvement</dc:subject>
          <dc:subject>immunomodulatory properties</dc:subject>
          <dc:subject>greater improvement</dc:subject>
          <dc:subject>epithelial damage</dc:subject>
          <dc:subject>behavioral responses</dc:subject>
          <dc:subject>associated proteins</dc:subject>
          <dc:description>&lt;p&gt;(Red pulp: RP; white pulp: WP; periarteriolar lymphocyte sheath: PALS; lymphoid follicles: LF; marginal zones: MZ; abnormal architecture: asterisk). The AR group demonstrated disruption of normal splenic architecture compared with controls. KYNA partially restored splenic organization, whereas desloratadine showed limited improvement. Samples include (A) Control, (B) AR, (C) Al(OH)&lt;sub&gt;3&lt;/sub&gt;, (D) KYNA, and (E) desloratadine groups. All images were obtained at ×40 magnification.&lt;/p&gt;</dc:description>
          <dc:date>2026-10-01T17:31:10Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.1371/journal.pone.0359624.g005</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/_p_Histopathological_examination_of_splenic_tissue_stained_with_hematoxylin_and_eosin_p_/34048238</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
